First Time Loading...

Natus Medical Inc
NASDAQ:NTUS

Watchlist Manager
Natus Medical Inc Logo
Natus Medical Inc
NASDAQ:NTUS
Watchlist
Price: 32.96 USD Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

NTUS price has not been updated for more than 6 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of NTUS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NTUS Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

2.4
P/S
P/S
Price to Sales
2.4
vs History
vs Industry
45
Median 3Y
2.4
Median 5Y
2.1
Industry
2.4
Forward
2.3
More Details
90
P/E
P/E
Price to Earnings
90
vs History
vs Industry
4
Median 3Y
85.8
Median 5Y
-40.1
Industry
23.4
Forward
22.9
More Details
23.7
P/OCF
P/OCF
Price to OCF
23.7
vs History
vs Industry
18
Median 3Y
17.8
Median 5Y
17.8
Industry
15.5
More Details
189.6
P/FCFE
P/FCFE
Price to FCFE
189.6
vs History
vs Industry
3
Median 3Y
19.1
Median 5Y
19.1
Industry
23.2
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
vs Industry
34
Median 3Y
2.7
Median 5Y
2.4
Industry
2.3
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
vs Industry
47
Median 3Y
2.2
Median 5Y
2
Industry
2.5
Forward
2.1
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
vs Industry
53
Median 3Y
3.8
Median 5Y
3.7
Industry
5.3
More Details
17.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.2
vs History
vs Industry
21
Median 3Y
18.4
Median 5Y
18.4
Industry
12.6
More Details
31.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31.3
vs History
vs Industry
14
Median 3Y
35.6
Median 5Y
35.9
Industry
17.2
More Details
21.9
EV/OCF
EV/OCF
Enterprise Value to OCF
21.9
vs History
vs Industry
20
Median 3Y
16.5
Median 5Y
16.5
Industry
15.3
More Details
23.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23.9
vs History
vs Industry
22
Median 3Y
17.5
Median 5Y
17.5
Industry
19.8
More Details
2.3
EV/IC
EV/IC
Enterprise Value to IC
2.3
vs History
vs Industry
33
Median 3Y
2.3
Median 5Y
1.9
Industry
2
More Details

Multiples Across Competitors

NTUS Competitors Multiples
Natus Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Natus Medical Inc
NASDAQ:NTUS
1.1B USD 2.4 90 17.2 31.3
US
Abbott Laboratories
NYSE:ABT
183.6B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.1 55.8 70
US
Stryker Corp
NYSE:SYK
125.1B USD 6 37.2 24.2 29.7
IE
Medtronic PLC
NYSE:MDT
108.6B USD 3.4 25.9 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.8B USD 7.3 60.5 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.6 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.4 28.5
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD 13.4 79.5 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
NTUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NTUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NTUS stock valuation using valuation multiples.
Wall Street Estimates
NTUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NTUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.